Acrivon Therapeutics, Inc. (ACRV): 4 filed Feb 18, 2026

Form type

4

Filing date

Feb 18, 2026

Accession number

0000905148-26-000935

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)